BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
3.440
-0.020 (-0.58%)
At close: Mar 28, 2024, 4:00 PM
3.390
-0.050 (-1.45%)
After-hours: Mar 28, 2024, 7:33 PM EDT

BioAtla Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
000.250.435.210.63
Revenue Growth (YoY)
---41.72%-91.75%-51.07%-
Gross Profit
000.250.435.210.63
Selling, General & Admin
25.9628.7938.4210.67.5512.56
Research & Development
103.7379.3558.2719.9325.9226.31
Operating Expenses
129.69108.1496.6930.5333.4738.86
Operating Income
-129.69-108.14-96.44-30.1-28.27-28.23
Interest Expense / Income
0001.391.630.95
Other Expense / Income
-6.23-1.66-1.044.37-0.1-0.2
Pretax Income
-123.46-106.48-95.4-35.85-29.79-28.98
Net Income
-123.46-106.48-95.4-35.85-29.79-28.98
Shares Outstanding (Basic)
48393585555
Shares Outstanding (Diluted)
48393585555
Shares Change
22.74%12.63%310.07%-84.56%--
EPS (Basic)
-2.58-2.74-2.76-3.19-0.53-0.52
EPS (Diluted)
-2.58-2.74-2.76-3.19-0.53-0.52
Free Cash Flow
-104.11-90.69-63.14-36.92-11.15-36.31
Free Cash Flow Per Share
-2.18-2.33-1.83-4.38-0.20-0.67
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---38576.00%-7016.08%-543.62%-265.68%
Profit Margin
---38160.80%-8357.34%-572.96%-272.69%
Free Cash Flow Margin
---25255.20%-8606.99%-214.50%-341.63%
EBITDA
-122.24-105.28-94.07-33.46-27.3-27.24
EBITDA Margin
---37627.60%-7798.60%-525.08%-256.29%
Depreciation & Amortization
1.221.21.331.010.860.79
EBIT
-123.46-106.48-95.4-34.46-28.16-28.03
EBIT Margin
---38159.60%-8033.57%-541.62%-263.76%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).